Published online before print January 23, 2006, doi: 10.1161/CIRCULATIONAHA.105.592592
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2006;113:577-582.)
© 2006 American Heart Association, Inc.
Vascular Medicine |
Massive Pulmonary Embolism
From the Cardiovascular Division, Department of Medicine, University Hospital Zurich, Zurich, Switzerland (N.K.); CINECA, Bologna, Italy (E.R., M.D.R.); and Cardiovascular Division, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass (S.Z.G.).
Correspondence to Samuel Z. Goldhaber, MD, Cardiovascular Division, Brigham and Women’s Hospital, 75 Francis St, Boston, MA 02115. E-mail sgoldhaber{at}partners.org
Received September 30, 2005; revision received October 28, 2005; accepted November 11, 2005.
Background— Acute massive pulmonary embolism (PE) carries an exceptionally high mortality rate. We explored how often adjunctive therapies, particularly thrombolysis and inferior vena caval (IVC) filter placement, were performed and how these therapies affected the clinical outcome of patients with massive PE.
Methods and Results— Among 2392 patients with acute PE and known systolic arterial blood pressure at presentation, from the International Cooperative Pulmonary Embolism Registry (ICOPER), 108 (4.5%) had massive PE, defined as a systolic arterial pressure <90 mm Hg, and 2284 (95.5%) had non–massive PE with a systolic arterial pressure 
90 mm Hg. PE was first diagnosed at autopsy in 16 patients (15%) with massive PE and in 29 patients (1%) with non–massive PE (P<0.001). The 90-day mortality rates were 52.4% (95% CI, 43.3% to 62.1%) and 14.7% (95% CI, 13.3% to 16.2%), respectively. In-hospital bleeding complications occurred in 17.6% versus 9.7% and recurrent PE within 90 days in 12.6% and 7.6%, respectively (P<0.001). In patients with massive PE, thrombolysis, surgical embolectomy, or catheter embolectomy were withheld in 73 (68%). Thrombolysis was performed in 33 patients, surgical embolectomy in 3, and catheter embolectomy in 1. Thrombolytic therapy did not reduce 90-day mortality (thrombolysis, 46.3%; 95% CI, 31.0% to 64.8%; no thrombolysis, 55.1%; 95% CI, 44.3% to 66.7%; hazard ratio, 0.79; 95% CI, 0.44 to 1.43). Recurrent PE rates at 90 days were similar in patients with and without thrombolytic therapy (12% for both; P=0.99). None of the 11 patients who received an IVC filter developed recurrent PE within 90 days, and 10 (90.9%) survived at least 90 days. IVC filters were associated with a reduction in 90-day mortality (hazard ratio, 0.12; 95% CI, 0.02 to 0.85).
Conclusions— In ICOPER, two thirds of the patients with massive PE did not receive thrombolysis or embolectomy. Counterintuitively, thrombolysis did not reduce mortality or recurrent PE at 90 days. The observed reduction in mortality from IVC filters requires further investigation.
CLINICAL PERSPECTIVE
This article has been cited by other articles:
 |
|
 |
|
  S. Konstantinides Acute Pulmonary Embolism N. Engl. J. Med., December 25, 2008; 359(26): 2804 - 2813. [Full Text] [PDF]
|
|
|
|
 |
|
 Authors/Task Force Members, A. Torbicki, A. Perrier, S. Konstantinides, G. Agnelli, N. Galie, P. Pruszczyk, F. Bengel, A. J.B. Brady, D. Ferreira, et al. Guidelines on the diagnosis and management of acute pulmonary embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) Eur. Heart J., September 2, 2008; 29(18): 2276 - 2315. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Ahmed, A. A. Khan, A. Smith, M. Pagala, S. Abrol, J. N. Cunningham Jr., and M. Vaynblat Expedient pulmonary embolectomy for acute pulmonary embolism: improved outcomes Interactive CardioVascular and Thoracic Surgery, August 1, 2008; 7(4): 591 - 594. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Kucher and S. Z. Goldhaber Mechanical Catheter Intervention in Massive Pulmonary Embolism: Proof of Concept Chest, July 1, 2008; 134(1): 2 - 4. [Full Text] [PDF]
|
|
|
|
|
|
G. Eid-Lidt, J. Gaspar, J. Sandoval, F. D. de los Santos, T. Pulido, H. Gonzalez Pacheco, and C. Martinez-Sanchez Combined Clot Fragmentation and Aspiration in Patients With Acute Pulmonary Embolism Chest, July 1, 2008; 134(1): 54 - 60. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Kearon, S. R. Kahn, G. Agnelli, S. Goldhaber, G. E. Raskob, and A. J. Comerota Antithrombotic Therapy for Venous Thromboembolic Disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 454S - 545S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Laporte, P. Mismetti, H. Decousus, F. Uresandi, R. Otero, J. L. Lobo, M. Monreal, and the RIETE Investigators Clinical Predictors for Fatal Pulmonary Embolism in 15 520 Patients With Venous Thromboembolism: Findings From the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry Circulation, April 1, 2008; 117(13): 1711 - 1716. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Otero, J. Trujillo-Santos, A. Cayuela, C. Rodriguez, M. Barron, J. J. Martin, M. Monreal, and and the Registro Informatizado de la Enfermedad Tr Haemodynamically unstable pulmonary embolism in the RIETE Registry: systolic blood pressure or shock index? Eur. Respir. J., December 1, 2007; 30(6): 1111 - 1116. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Kucher Catheter Embolectomy for Acute Pulmonary Embolism Chest, August 1, 2007; 132(2): 657 - 663. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Carlbom and B. L. Davidson Pulmonary Embolism in the Critically Ill Chest, July 1, 2007; 132(1): 313 - 324. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Piazza and S. Z. Goldhaber Acute Pulmonary Embolism: Part II: Treatment and Prophylaxis Circulation, July 18, 2006; 114(3): e42 - e47. [Full Text] [PDF]
|
|
|
|
 |
|
 Fibrinolysis for Massive Pulmonary Embolism: Logical but Untested Journal Watch Emergency Medicine, April 25, 2006; 2006(425): 13 - 13. [Full Text]
|
|